English

Twist Bioscience Corp

EDGAR

TWST Quarterly report (10-Q) · filed 2026-08-03

53 filing records in this dataset, filed from 2016-01-20 to 2026-08-03. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 117 million USD 2026-06-30 Source
Exact value

117436000 USD
Long-term debt including current maturities: 4.17 million USD 2020-09-30 Source
Exact value

4166000 USD
Shares outstanding: 62.7 million shares 2026-06-30 Source
Exact value

62674000 shares

Reported share-count change

4.15% · 2.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

60174000 shares · 2025-06-30· Source
62674000 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-137 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -77670000 USD · 2024-10-01 – 2025-09-30 Source
Net income: -50532000 USD · 2024-10-01 – 2025-06-30 Source
Net income: -30507000 USD · 2025-10-01 – 2025-12-31 Source
Net income: -44021000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -35051000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-53.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -47628000 USD · 2024-10-01 – 2025-09-30 Source
Operating cash flow: -35814000 USD · 2024-10-01 – 2025-06-30 Source
Operating cash flow: -24814000 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -42373000 USD · 2025-10-01 – 2026-03-31 Source
Operating cash flow: -24814000 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -41258000 USD · 2025-10-01 – 2026-06-30 Source
Operating cash flow: -42373000 USD · 2025-10-01 – 2026-03-31 Source

Capital expenditure

40.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 28004000 USD · 2024-10-01 – 2025-09-30 Source
Capital expenditure: 15577000 USD · 2024-10-01 – 2025-06-30 Source
Capital expenditure: 9974000 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 17861000 USD · 2025-10-01 – 2026-03-31 Source
Capital expenditure: 9974000 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 27624000 USD · 2025-10-01 – 2026-06-30 Source
Capital expenditure: 17861000 USD · 2025-10-01 – 2026-03-31 Source

Free cash flow

-93.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -47628000 USD · 2024-10-01 – 2025-09-30 Source
Operating cash flow: -35814000 USD · 2024-10-01 – 2025-06-30 Source
Operating cash flow: -24814000 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -42373000 USD · 2025-10-01 – 2026-03-31 Source
Operating cash flow: -24814000 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -41258000 USD · 2025-10-01 – 2026-06-30 Source
Operating cash flow: -42373000 USD · 2025-10-01 – 2026-03-31 Source
Capital expenditure: 28004000 USD · 2024-10-01 – 2025-09-30 Source
Capital expenditure: 15577000 USD · 2024-10-01 – 2025-06-30 Source
Capital expenditure: 9974000 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 17861000 USD · 2025-10-01 – 2026-03-31 Source
Capital expenditure: 9974000 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 27624000 USD · 2025-10-01 – 2026-06-30 Source
Capital expenditure: 17861000 USD · 2025-10-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-03.

Financial data available through: 2025-09-30.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2025-09-30
Net income: 9 of 11 periods available· newest 2025-09-30
Operating cash flow: 9 of 11 periods available· newest 2025-09-30
Capital expenditure: 9 of 11 periods available· newest 2025-09-30
Total assets: 8 of 11 periods available· newest 2025-09-30
Total liabilities: 8 of 11 periods available· newest 2025-09-30
Current assets: 8 of 11 periods available· newest 2025-09-30
Current liabilities: 8 of 11 periods available· newest 2025-09-30
Cash and cash equivalents: 9 of 11 periods available· newest 2025-09-30
Long-term debt including current maturities: 2 of 11 periods available· newest 2020-09-30
Shares outstanding: 8 of 11 periods available· newest 2025-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 131.06 million

Prior period

−USD 208.73 million

2023-10-01 – 2024-09-30
Current period

−USD 77.67 million

2024-10-01 – 2025-09-30

Exact inputs and evidence

-77670000 − -208726000 = 131056000 USD

-208726000 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
-77670000 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Year-over-year change in Net income: 131056000 USD Concept: fundies:NetIncome Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -77670000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1672744 Filing: 000158128025000025 Input fundies:NetIncome: -208726000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1673516 Filing: 000158128025000025
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 16.47 million

Prior period

−USD 64.09 million

2023-10-01 – 2024-09-30
Current period

−USD 47.63 million

2024-10-01 – 2025-09-30

Exact inputs and evidence

-47628000 − -64094000 = 16466000 USD

-64094000 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
-47628000 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Year-over-year change in Operating cash flow: 16466000 USD Concept: fundies:OperatingCashFlow Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -47628000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1010121 Filing: 000158128025000025 Input fundies:OperatingCashFlow: -64094000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1011015 Filing: 000158128025000025
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+451.7%

Prior period

USD 5.08 million

2023-10-01 – 2024-09-30
Current period

USD 28 million

2024-10-01 – 2025-09-30

Exact inputs and evidence

28004000 − 5076000 = 22928000 USD

5076000 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
28004000 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Year-over-year change in Capital expenditure: 22928000 USD Concept: fundies:CapitalExpenditure Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 28004000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1013801 Filing: 000158128025000025 Input fundies:CapitalExpenditure: 5076000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1014590 Filing: 000158128025000025
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-10-01 – 2017-09-30	−USD 59.31 million Exact value Exact value: -59310000 USD 2016-10-01 – 2017-09-30: -59310000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2017-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -59310000 USD Concept: fundies:NetIncome Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:NetIncome: -59310000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312519313115/twst-20190930.xml#256273 Filing: 000119312519313115 The citation records this snapshot. The page link may show a newer release later.	−USD 51.3 million Exact value Exact value: -51301000 USD 2016-10-01 – 2017-09-30: -51301000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2017-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -51301000 USD Concept: fundies:OperatingCashFlow Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51301000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312519313115/twst-20190930.xml#208079 Filing: 000119312519313115 The citation records this snapshot. The page link may show a newer release later.	USD 6.59 million Exact value Exact value: 6594000 USD 2016-10-01 – 2017-09-30: 6594000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2017-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 6594000 USD Concept: fundies:CapitalExpenditure Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6594000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312519313115/twst-20190930.xml#206688 Filing: 000119312519313115 The citation records this snapshot. The page link may show a newer release later.	−USD 57.9 million Calculation and evidence -51301000 − 6594000 USD Exact free cash flow: -57895000 USD 2016-10-01 – 2017-09-30: -51301000 USD · Inspect Operating Cash Flow · Source 2016-10-01 – 2017-09-30: 6594000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2017-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -57895000 USD Concept: free-cash-flow Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51301000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312519313115/twst-20190930.xml#208079 Filing: 000119312519313115 Input fundies:CapitalExpenditure: 6594000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312519313115/twst-20190930.xml#206688 Filing: 000119312519313115 The citation records this snapshot. The page link may show a newer release later.
2018 2017-10-01 – 2018-09-30	−USD 71.24 million Exact value Exact value: -71236000 USD 2017-10-01 – 2018-09-30: -71236000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2018-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -71236000 USD Concept: fundies:NetIncome Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:NetIncome: -71236000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#257646 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.	−USD 66.16 million Exact value Exact value: -66164000 USD 2017-10-01 – 2018-09-30: -66164000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2018-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -66164000 USD Concept: fundies:OperatingCashFlow Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -66164000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#208900 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.	USD 3.69 million Exact value Exact value: 3688000 USD 2017-10-01 – 2018-09-30: 3688000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2018-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 3688000 USD Concept: fundies:CapitalExpenditure Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3688000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#209515 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.	−USD 69.85 million Calculation and evidence -66164000 − 3688000 USD Exact free cash flow: -69852000 USD 2017-10-01 – 2018-09-30: -66164000 USD · Inspect Operating Cash Flow · Source 2017-10-01 – 2018-09-30: 3688000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2018-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -69852000 USD Concept: free-cash-flow Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -66164000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#208900 Filing: 000119312520303904 Input fundies:CapitalExpenditure: 3688000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#209515 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.
2019 2018-10-01 – 2019-09-30	−USD 107.67 million Exact value Exact value: -107669000 USD 2018-10-01 – 2019-09-30: -107669000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2019-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -107669000 USD Concept: fundies:NetIncome Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:NetIncome: -107669000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#257497 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.	−USD 87.94 million Exact value Exact value: -87937000 USD 2018-10-01 – 2019-09-30: -87937000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2019-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -87937000 USD Concept: fundies:OperatingCashFlow Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -87937000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#208694 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.	USD 14.76 million Exact value Exact value: 14757000 USD 2018-10-01 – 2019-09-30: 14757000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2019-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 14757000 USD Concept: fundies:CapitalExpenditure Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14757000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#209310 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.	−USD 102.69 million Calculation and evidence -87937000 − 14757000 USD Exact free cash flow: -102694000 USD 2018-10-01 – 2019-09-30: -87937000 USD · Inspect Operating Cash Flow · Source 2018-10-01 – 2019-09-30: 14757000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2019-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -102694000 USD Concept: free-cash-flow Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -87937000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#208694 Filing: 000119312520303904 Input fundies:CapitalExpenditure: 14757000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000119312520303904/twst-20200930.xml#209310 Filing: 000119312520303904 The citation records this snapshot. The page link may show a newer release later.
2020 2019-10-01 – 2020-09-30	−USD 139.93 million Exact value Exact value: -139931000 USD 2019-10-01 – 2020-09-30: -139931000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2020-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -139931000 USD Concept: fundies:NetIncome Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:NetIncome: -139931000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023020881/twst-20220930.htm#1492404 Filing: 000162828023020881 The citation records this snapshot. The page link may show a newer release later.	−USD 142.26 million Exact value Exact value: -142255000 USD 2019-10-01 – 2020-09-30: -142255000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2020-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -142255000 USD Concept: fundies:OperatingCashFlow Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -142255000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023020881/twst-20220930.htm#604252 Filing: 000162828023020881 The citation records this snapshot. The page link may show a newer release later.	USD 9.87 million Exact value Exact value: 9868000 USD 2019-10-01 – 2020-09-30: 9868000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2020-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 9868000 USD Concept: fundies:CapitalExpenditure Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9868000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023020881/twst-20220930.htm#608372 Filing: 000162828023020881 The citation records this snapshot. The page link may show a newer release later.	−USD 152.12 million Calculation and evidence -142255000 − 9868000 USD Exact free cash flow: -152123000 USD 2019-10-01 – 2020-09-30: -142255000 USD · Inspect Operating Cash Flow · Source 2019-10-01 – 2020-09-30: 9868000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2020-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -152123000 USD Concept: free-cash-flow Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -142255000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023020881/twst-20220930.htm#604252 Filing: 000162828023020881 Input fundies:CapitalExpenditure: 9868000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023020881/twst-20220930.htm#608372 Filing: 000162828023020881 The citation records this snapshot. The page link may show a newer release later.
2021 2020-10-01 – 2021-09-30	−USD 152.1 million Exact value Exact value: -152098000 USD 2020-10-01 – 2021-09-30: -152098000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2021-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -152098000 USD Concept: fundies:NetIncome Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:NetIncome: -152098000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023039767/twst-20230930.htm#1899268 Filing: 000162828023039767 The citation records this snapshot. The page link may show a newer release later.	−USD 112.24 million Exact value Exact value: -112244000 USD 2020-10-01 – 2021-09-30: -112244000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2021-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -112244000 USD Concept: fundies:OperatingCashFlow Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -112244000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023039767/twst-20230930.htm#1240915 Filing: 000162828023039767 The citation records this snapshot. The page link may show a newer release later.	USD 27.06 million Exact value Exact value: 27061000 USD 2020-10-01 – 2021-09-30: 27061000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2021-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 27061000 USD Concept: fundies:CapitalExpenditure Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27061000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023039767/twst-20230930.htm#1243880 Filing: 000162828023039767 The citation records this snapshot. The page link may show a newer release later.	−USD 139.31 million Calculation and evidence -112244000 − 27061000 USD Exact free cash flow: -139305000 USD 2020-10-01 – 2021-09-30: -112244000 USD · Inspect Operating Cash Flow · Source 2020-10-01 – 2021-09-30: 27061000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2021-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -139305000 USD Concept: free-cash-flow Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -112244000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023039767/twst-20230930.htm#1240915 Filing: 000162828023039767 Input fundies:CapitalExpenditure: 27061000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828023039767/twst-20230930.htm#1243880 Filing: 000162828023039767 The citation records this snapshot. The page link may show a newer release later.
2022 2021-10-01 – 2022-09-30	−USD 217.86 million Exact value Exact value: -217863000 USD 2021-10-01 – 2022-09-30: -217863000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2022-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -217863000 USD Concept: fundies:NetIncome Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:NetIncome: -217863000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828024048262/twst-20240930.htm#1852372 Filing: 000162828024048262 The citation records this snapshot. The page link may show a newer release later.	−USD 124.39 million Exact value Exact value: -124385000 USD 2021-10-01 – 2022-09-30: -124385000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2022-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -124385000 USD Concept: fundies:OperatingCashFlow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -124385000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828024048262/twst-20240930.htm#1121250 Filing: 000162828024048262 The citation records this snapshot. The page link may show a newer release later.	USD 101.86 million Exact value Exact value: 101857000 USD 2021-10-01 – 2022-09-30: 101857000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2022-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 101857000 USD Concept: fundies:CapitalExpenditure Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 101857000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828024048262/twst-20240930.htm#1124783 Filing: 000162828024048262 The citation records this snapshot. The page link may show a newer release later.	−USD 226.24 million Calculation and evidence -124385000 − 101857000 USD Exact free cash flow: -226242000 USD 2021-10-01 – 2022-09-30: -124385000 USD · Inspect Operating Cash Flow · Source 2021-10-01 – 2022-09-30: 101857000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2022-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -226242000 USD Concept: free-cash-flow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -124385000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828024048262/twst-20240930.htm#1121250 Filing: 000162828024048262 Input fundies:CapitalExpenditure: 101857000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000162828024048262/twst-20240930.htm#1124783 Filing: 000162828024048262 The citation records this snapshot. The page link may show a newer release later.
2023 2022-10-01 – 2023-09-30	−USD 204.62 million Exact value Exact value: -204618000 USD 2022-10-01 – 2023-09-30: -204618000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2023-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -204618000 USD Concept: fundies:NetIncome Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2023-09-30&surface=latest&period_type=duration&start=2022-10-01&unit=USD&dimensions= Input fundies:NetIncome: -204618000 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1674289 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	−USD 142.47 million Exact value Exact value: -142474000 USD 2022-10-01 – 2023-09-30: -142474000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2023-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -142474000 USD Concept: fundies:OperatingCashFlow Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2023-09-30&surface=latest&period_type=duration&start=2022-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -142474000 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1011909 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	USD 27.78 million Exact value Exact value: 27779000 USD 2022-10-01 – 2023-09-30: 27779000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2023-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 27779000 USD Concept: fundies:CapitalExpenditure Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2023-09-30&surface=latest&period_type=duration&start=2022-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27779000 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1015378 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	−USD 170.25 million Calculation and evidence -142474000 − 27779000 USD Exact free cash flow: -170253000 USD 2022-10-01 – 2023-09-30: -142474000 USD · Inspect Operating Cash Flow · Source 2022-10-01 – 2023-09-30: 27779000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2023-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -170253000 USD Concept: free-cash-flow Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -142474000 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1011909 Filing: 000158128025000025 Input fundies:CapitalExpenditure: 27779000 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1015378 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.
2024 2023-10-01 – 2024-09-30	−USD 208.73 million Exact value Exact value: -208726000 USD 2023-10-01 – 2024-09-30: -208726000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2024-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -208726000 USD Concept: fundies:NetIncome Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2024-09-30&surface=latest&period_type=duration&start=2023-10-01&unit=USD&dimensions= Input fundies:NetIncome: -208726000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1673516 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	−USD 64.09 million Exact value Exact value: -64094000 USD 2023-10-01 – 2024-09-30: -64094000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2024-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -64094000 USD Concept: fundies:OperatingCashFlow Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2024-09-30&surface=latest&period_type=duration&start=2023-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64094000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1011015 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	USD 5.08 million Exact value Exact value: 5076000 USD 2023-10-01 – 2024-09-30: 5076000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2024-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 5076000 USD Concept: fundies:CapitalExpenditure Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2024-09-30&surface=latest&period_type=duration&start=2023-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5076000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1014590 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	−USD 69.17 million Calculation and evidence -64094000 − 5076000 USD Exact free cash flow: -69170000 USD 2023-10-01 – 2024-09-30: -64094000 USD · Inspect Operating Cash Flow · Source 2023-10-01 – 2024-09-30: 5076000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2024-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -69170000 USD Concept: free-cash-flow Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64094000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1011015 Filing: 000158128025000025 Input fundies:CapitalExpenditure: 5076000 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1014590 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.
2025 2024-10-01 – 2025-09-30	−USD 77.67 million Exact value Exact value: -77670000 USD 2024-10-01 – 2025-09-30: -77670000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Net Income: -77670000 USD Concept: fundies:NetIncome Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ANetIncome&period=2025-09-30&surface=latest&period_type=duration&start=2024-10-01&unit=USD&dimensions= Input fundies:NetIncome: -77670000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1672744 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	−USD 47.63 million Exact value Exact value: -47628000 USD 2024-10-01 – 2025-09-30: -47628000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Operating Cash Flow: -47628000 USD Concept: fundies:OperatingCashFlow Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3AOperatingCashFlow&period=2025-09-30&surface=latest&period_type=duration&start=2024-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47628000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1010121 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	USD 28 million Exact value Exact value: 28004000 USD 2024-10-01 – 2025-09-30: 28004000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Capital Expenditure: 28004000 USD Concept: fundies:CapitalExpenditure Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280/explain?concept=fundies%3ACapitalExpenditure&period=2025-09-30&surface=latest&period_type=duration&start=2024-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28004000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1013801 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.	−USD 75.63 million Calculation and evidence -47628000 − 28004000 USD Exact free cash flow: -75632000 USD 2024-10-01 – 2025-09-30: -47628000 USD · Inspect Operating Cash Flow · Source 2024-10-01 – 2025-09-30: 28004000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Twist Bioscience Corp · 2025-09-30 Twist Bioscience Corp (edgar:1581280) Free cash flow: -75632000 USD Concept: free-cash-flow Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1581280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47628000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1010121 Filing: 000158128025000025 Input fundies:CapitalExpenditure: 28004000 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm#1013801 Filing: 000158128025000025 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

53 filings · 2,924 latest values · 2,924 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001581280, 1581280, TWST, edgar:1581280

Also known as Twist Bioscience Corp, Twist Bioscience Corporation

Twist Bioscience Corp

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation